Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Emberson

Showing results (61-70 of 109) with videos related to

Pageof 11
Sort By:
Heart (British Cardiac Society)|September 10, 2024
Lifetime effects and cost-effectiveness of statin therapy for older people in the United Kingdom: a modelling studyBorislava Mihaylova, Runguo Wu, Junwen Zhou, et al.
International Journal of Epidemiology|November 7, 2023
Independent relevance of adiposity measures to coronary heart disease risk among 0.5 million adults in UK BiobankEirini Trichia, Debbie E Malden, Danyao Jin, et al.
JAMA Network Open|September 25, 2020
Association of Blood Pressure With Cause-Specific Mortality in Mexican AdultsRoberto Tapia-Conyer, Jesus Alegre-Díaz, Louisa Gnatiuc, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 25, 2015
Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP)Borislava Mihaylova, Iryna Schlackow, William Herrington, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 15, 2014
The effect of lowering LDL cholesterol on vascular access patency: post hoc analysis of the Study of Heart and Renal ProtectionWilliam Herrington, Jonathan Emberson, Natalie Staplin, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 3, 2025
Cost-effectiveness of fenofibrate versus standard care for reducing the progression of diabetic retinopathy: An economic evaluation based on data from the LENS trialGraham Scotland, Mekazin Tsehaye, Caroline Styles, et al.
JAMA|May 20, 2026
Weight Loss in Older Patients With Persistent Atrial Fibrillation: The LOSE-AF Randomized Clinical TrialMatteo Sclafani, Marco Spartera, Yasmin Esmati, et al.
Health Technology Assessment (Winchester, England)|May 12, 2026
Fenofibrate and progression of retinopathy in adults with diabetes: the randomised placebo-controlled LENS trialDavid Preiss, Jennifer Logue, Emily Sammons, et al.
Hypertension (Dallas, Tex. : 1979)|December 29, 2016
Evidence for Reverse Causality in the Association Between Blood Pressure and Cardiovascular Risk in Patients With Chronic Kidney DiseaseWilliam Herrington, Natalie Staplin, Parminder K Judge, et al.
Hypertension (Dallas, Tex. : 1979)|September 9, 2022
Determining the Relationship Between Blood Pressure, Kidney Function, and Chronic Kidney Disease: Insights From Genetic EpidemiologyNatalie Staplin, William G Herrington, Federico Murgia, et al.
Pageof 11

Showing results (61-70 of 109) with videos related to

Sort By:
Pageof 11
Heart (British Cardiac Society)|September 10, 2024
Lifetime effects and cost-effectiveness of statin therapy for older people in the United Kingdom: a modelling studyBorislava Mihaylova, Runguo Wu, Junwen Zhou, et al.
International Journal of Epidemiology|November 7, 2023
Independent relevance of adiposity measures to coronary heart disease risk among 0.5 million adults in UK BiobankEirini Trichia, Debbie E Malden, Danyao Jin, et al.
JAMA Network Open|September 25, 2020
Association of Blood Pressure With Cause-Specific Mortality in Mexican AdultsRoberto Tapia-Conyer, Jesus Alegre-Díaz, Louisa Gnatiuc, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 25, 2015
Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP)Borislava Mihaylova, Iryna Schlackow, William Herrington, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 15, 2014
The effect of lowering LDL cholesterol on vascular access patency: post hoc analysis of the Study of Heart and Renal ProtectionWilliam Herrington, Jonathan Emberson, Natalie Staplin, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 3, 2025
Cost-effectiveness of fenofibrate versus standard care for reducing the progression of diabetic retinopathy: An economic evaluation based on data from the LENS trialGraham Scotland, Mekazin Tsehaye, Caroline Styles, et al.
JAMA|May 20, 2026
Weight Loss in Older Patients With Persistent Atrial Fibrillation: The LOSE-AF Randomized Clinical TrialMatteo Sclafani, Marco Spartera, Yasmin Esmati, et al.
Health Technology Assessment (Winchester, England)|May 12, 2026
Fenofibrate and progression of retinopathy in adults with diabetes: the randomised placebo-controlled LENS trialDavid Preiss, Jennifer Logue, Emily Sammons, et al.
Hypertension (Dallas, Tex. : 1979)|December 29, 2016
Evidence for Reverse Causality in the Association Between Blood Pressure and Cardiovascular Risk in Patients With Chronic Kidney DiseaseWilliam Herrington, Natalie Staplin, Parminder K Judge, et al.
Hypertension (Dallas, Tex. : 1979)|September 9, 2022
Determining the Relationship Between Blood Pressure, Kidney Function, and Chronic Kidney Disease: Insights From Genetic EpidemiologyNatalie Staplin, William G Herrington, Federico Murgia, et al.
Pageof 11